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 The synthesis of several branched oligonucleotides (parallel hairpins 11-14, and 
Y-shape 15 oligonucleotides) is described together with their use in the formation 
of pyrimidine-pyrimidine-purine triple helices. Special attention was paid to the 
optimization of the assembly of the second strand using asymmetric branching 
molecules. The presence of 8-aminoadenine in the Watson-Crick purine strand 
and 2’-O-methyl-RNA in the Hoogsteen pyrimidine strand produced strong 
stabilization of the triplex. 
 
Introduction.- Oligonucleotides bind in a sequence-specific manner to 
homopurine-homopyrimidine sequences of duplex and single-stranded DNA and 
RNA to form triplexes [1]. Nucleic acid triplexes have potential applications in 
diagnostics, gene analysis and therapy [1, 2]. Recently, it has been reported that 
oligonucleotides carrying 8-aminopurine nucleosides formed stable pyrimidine-
pyrimidine-purine triplexes [3-6]. These triplex stabilization properties of 8-
aminopurines can be used to capture specific polypyrimidine sequences using 
parallel stranded hairpins with a polypyrimidine sequence linked to the 
complementary purine strand carrying 8-aminopurines [7, 8]. The binding 
properties of parallel hairpins carrying 8-aminopurines stimulated the search for 
new types of hairpins with even better binding properties.    
One interesting possibility is to use branched oligonucleotides [9 and references 
cited herein]. Most of the work dealing with branched oligonucleotides was first 
focused on the study of these compounds as splicing intermediates of eukaryotic 
mRNAs [10-12]. Moreover, branched nucleic acids have been prepared using 
nucleoside branching points other than the 2’ and 3’ positions of  a ribonucleoside 
such as 4’-C-(hydroxymethyl)thymidine [13, 14], arabino-uridine [15] or through 
the nucleobase [16, 17]. The complexity of the synthesis of the branching 
molecules and the low yields obtained triggered the search for non-nucleoside 
branching molecules such as derivatives of 1,2,6-hexanetriol [18], 1,3-
diaminopropanol [19] and pentaerythriol [20, 21]. These branching molecules can 
produce dendrimeric oligonucleotides which may be used as polylabelled DNA 
probes to increase sensitivity in hybridization experiments [17-20]. Moreover, 
oligonucleotides with three arms were found to be efficient templates for the 
directed synthesis of trimeric structures [22]. Finally, branched oligonucleotides 
have been used to produce V-shape oligonucleotides with high affinity to single-
stranded DNA or RNA by triplex formation [9, 14, 15, 17, 21, 23, 24]  and to 
form alternate-strand triplexes [25, 26].  
Here we report the synthesis of parallel stranded hairpins using a non-
nucleoside branching molecule. We also describe their use in the formation of 
pyrimidine-pyrimidine-purine triple helices. The previous method of synthesis 
[27, 28] requires the use of reverse phosphoramidites to build the half of the 
molecule (scheme 1). In the present paper the hairpins are synthesized from the 
middle of the molecule by the extension of one branch of an asymmetric 
branching molecule, followed by assembly of the next branch. The combination of 
an acid labile group (dimetoxytrityl, (MeO)2Tr) and a base labile group (9-
fluorenylmethyloxycarbonyl, Fmoc) allows the assembly of the desired molecule 
without the need of reverse phosphoramidites. Finally, the three strands of a 
triplex were connected together with a three-branched Y-shape oligonucleotide 
using the asymmetric branching molecule. The binding properties of these 
molecules are discussed.    
  
Results. - 1. Structure of the oligonucleotide derivatives  Oligonucleotides 
sequences of hairpins are shown in Table 1. The sequences of the hairpins are 
based on a triplex model sequence described previously [29, 30]. Here, the 
Hoogsteen polypyrimidine strand was linked to the Watson-Crick polypurine 
strand.  
The first group of sequences (7-10) are parallel stranded and the polypurine strand 
is connected with the Hoogsteen polypyrimidine strand either by their 3’ ends (7, 
8) or by their 5’ ends (9, 10) through a hexaethyleneglycol linker [(EG)6]. In 
hairpins 8 and 9, two adenines were replaced by two 8-aminoadenines. These 
hairpins were prepared by the standard method using a combination of standard 
and reversed phosphoramidites (scheme 1, [27, 28]). The binding properties of 
these hairpins have been described previously [7, 8] and they are used for 
comparison purposes.   
The second group of sequences (11, 12) are 3’-3’ linked parallel hairpins like 7. 
The hexaethyleneglycol loop of 7 is replaced by 4-hydroxybutyric (11) and 5-
hydroxypentanoic (12) derivatives of 1,3-diaminopropanol and four thymidines 
(Table 1). These hairpins were prepared from the middle of the loop using an 
asymmetric branching molecule as outlined in part B of scheme 1. A solid support 
carrying the asymmetric branching molecule (scheme 2) was used for the 
preparation of 11. In contrast, a phosphoramidite of the asymmetric branching 
molecule was used for the synthesis of 12. This phosphoramidite was coupled to a 
solid support carrying a 1,3-propanediol molecule [31]. In this way the difference 
between 11 and 12 is a 3-hydroxypropyl phosphate in the loop. The synthesis of 
11 and 12 were used to find the optimal conditions for the assembly of the 
sequences using asymmetric doublers. In this method, the combination of an acid 
labile group ((MeO)2Tr) and a base labile group (Fmoc) allows the assembly of 
the hairpin from the middle of the loop. After the assembly of the first strand, the 
Fmoc group is removed and, the second strand is then synthesized.  
The third group of sequences (13 and 14) are derivatives of 12 carrying two 
different types of substitutions. First, in both hairpins (13 and 14) two adenines 
were replaced by two 8-aminoadenines. In addition the whole Hoogsteen 
polypyrimidine strand of hairpin 13 was replaced by 2’-O-methyl-RNA backbone, 
and the six C in the hairpin 14 were replaced by 5-methyl-C. The introduction of 
RNA and 2’-O-methyl-RNA [32-36] as well as 5-methyl-C [29, 37, 38] in the 
Hoogsteen polypyrimidine strand have been reported to stabilize triplexes. We 
were interested in analyzing whether these stabilizing properties are additive to 
the triplex stabilizing properties of 8-aminoadenine found in parallel hairpins. 
These hairpins were synthesized using the optimal conditions found in the 
synthesis of 12. These optimal conditions were also used for the synthesis of a 
three-branched oligonucleotide having the three strands of a triplex (15, Table 1). 
 
2. Synthesis of parallel hairpins. The asymmetric branching phosphoramidites 
was obtained from commercial sources. The synthetic scheme for the preparation 
of  the solid support carrying asymmetric branching molecule is shown in scheme 
1. 1, 3-Diamino-2-propanol was reacted with γ-butyrolactone to yield the desired 
triol 1 [19]. Next we tried the introduction of the (MeO)2Tr group in one position 
by limiting the amount of dimethoxytrityl chloride. The mono-(MeO)2Tr-product 
was formed but the desired product was isolated from the di-(MeO)2Tr- product in 
very low yields. Reaction of the mono-(MeO)2Tr-derivative (with and without 
isolation of the di-(MeO)2Tr-product) with 9-fluorenylmethoxycarbonyl chloride 
gave the desired product but again the recovery from the silica gel purification 
was low. The introduction of the Fmoc- group first followed by the addition of the 
(MeO)2Tr group also yielded little product after silica gel purification, although 
the Fmoc group was more stable in the silica gel chromatography than the 
(MeO)2Tr group. Finally, we selected the more stable monomethoxytrityl 
(MeOTr) group for the protection of the alcohol function and the desired 
monofunctionalized derivative 2 was isolated in good yields. The introduction of 
the Fmoc group also proceeded in moderate but better yields than before. 
Compound 3 was further derivatized to obtain the solid support  5 (Scheme 2) 
following standard protocols.  
Sequence 11 was used as model compound to study the synthesis of 
oligonucleotides having two different branches (Scheme 3). The first branch was 
assembled on 1 μmol-scale using standard synthesis cycle. The resulting support 
was acetylated and the Fmoc group was removed by treatment with 0.5 M 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) solution in acetonitrile (ACN) (10 min). 
Aliquots of 0.2 μmols of support were subjected to 6 different synthesis cycles as 
described in methods. The changes introduced were the increase of reaction times 
especially coupling time, double coupling protocols, introduction of an extra wash 
using a dimethylaminopyridine (DMAP) - tetrazole (TET) solution and non-
aqueous oxidation. 
In some experiments we introduced a wash in DMAP-TET between detritylation 
and coupling. During the removal of the Fmoc group a strong base was used 
(DBU) and, in these conditions, the 2-cyanoethyl (CNE) group which protects 
phosphate groups was also removed. The presence of unprotected phosphates 
during the assembly of oligonucleotides may explain the low yields obtained 
during the assembly of the second branch. In a similar situation the use of DMAP-
TET was recommended [39].  
The progress of the assembly of the second strand was monitored by the 
absorption of the (MeO)2Tr group released after each coupling. The first and 
second coupling after branching were lower than the rest. Standard cycle (A) gave 
60% overall yield. Increasing the coupling time (cycle B) and double coupling 
(coupling C) were the best conditions giving a 90% overall yield. The use of non-
aqueous oxidation (cycle F) give no significant differences. The use of DMAP-
TET gave lower yields than the standard cycle (30% overall yield). 
The results obtained by the measurement of the trityl released during the acid 
treatments were confirmed by gel electrophoresis (Figure 1). Moreover, the 
truncated sequences were mainly observed near the branching point. The resulting 
oligonucleotide (11) was purified using the trityl-on and trityl-off protocols and 
the purified  compound was characterized by mass spectrometry. 
In addition we built the first strand using phosphoramidites carrying methoxy 
groups instead of the CNE group. Previous reports on the synthesis of branched 
oligonucleotides describe the use of methyl phosphoramidites [10-13]. In our 
model compound the use of methyl phosphoramidites was not satisfactory. The 
coupling efficiency of the second strand was slightly worse than using CNE- 
phosphoramidites and the crude product was clearly more impurified of shorter 
sequences near the branching point (data not shown).  
Next, the assembly of sequence 12 was performed. In this sequence, the 
phosphoramidite of the branching molecule is added to a solid support carrying a 
1,3-propandiol molecule [31]. We assayed various changes in the cycle (described 
in methods). As observed before, yields of the first and second coupling reactions 
were low, but in this case even lower than before. Using the standard cycle the 
overall yield was only 20%. The use of tert-butylhydroperoxide instead of iodine 
was slightly better. Increasing the coupling time increased the overall yield to 
60%. Increasing the time and the concentration of the phosphoramidite or using a 
double coupling protocol increased the overall yield to 80-90%. The presence of 
the phosphate near the branching point reduced the coupling yields of the second 
branch, but this effect was overcome by increasing time and the concentration of 
the phosphoramidite. 
Next, sequences 13 and 14 carrying 8-aminoadenines were prepared. First the 
polypurine sequence was assembled on a solid support carrying the asymmetric 
branching molecule coupled to 1,3-propanediol. Upon completion of the 
polypurine sequence, the support was removed from the synthesizer and 
acetylation followed by the removal of the Fmoc group was performed in a 
syringe. Finally, the polypyrimidine strand was assembled using a synthesis cycle 
with the double coupling protocol. The assembly of the second strand proceeded 
with an overall yield of 80%. The resulting oligonucleotides were purified using 
the trityl-on and trityl-off protocols and the homogeneity was checked by gel 
electrophoresis. 
Finally, the three-branched oligonucleotide (15) was prepared on polystyrene 
supports (LV200, Applied Biosystems). First the Watson-Crick pyrimidine strand 
was assembled, followed by the addition of hexaethyleneglycol and the 
asymmetric branching molecule. The synthesis was continued by the addition of 
hexaethyleneglycol and the assembly of the Watson-Crick purine strand. At this 
point, the (MeO)2Tr-support was detritylated and acetylated followed by the 
removal of the Fmoc group as described above. A third hexaethyleneglycol 
molecule was then added followed by the assembly of the Hoogsteen pyrimidine 
strand. (Scheme 4). Standard phosphoramidites were used. The three strands were 
assembled using the synthesis cycle recommended for low-volume columns. A 
longer coupling time (480 s instead of 40 s) was used only during the assembly of 
the third strand. The assembly of the third strand proceeded with an overall yield 
of 80%.  The resulting oligonucleotide (15) was purified using the trityl-on and 
trityl-off protocols and the homogeneity was checked by gel electrophoresis. 
 
3. Thermal denaturation experiments.  The relative stability of triple helices 
formed by parallel hairpins and the polypyrimidine target sequences was 
measured spectrophotometrically. In all cases, one single transition was observed, 
which was assigned to the transition from triple helix to random coil [8]. Table 2 
shows the melting temperatures of triplexes made by mixing parallel hairpins 11-
14  with the natural polypyrimidine target sequence (S11WC), the 2’-O-methyl-
RNA target sequence (S11RNA) and the 5-methyl-C substituted target sequence 
(S11meC). For comparison, melting temperatures of hairpins 7-10 are also shown. 
When hairpins were heated alone without the target sequence, a transition from 
parallel duplex to random coil is also observed. In all cases except one (14) this 
transition has a lower melting temperature and a lower hyperchromicity. Hairpin 
11 has a similar melting temperature to hairpins 7 and 9, but that of hairpin 12 is 
6-7 ºC lower. Hairpins having two 8-amino-A residues have higher melting 
temperatures (ΔTM 13 ºC for 10 and ΔTM 18 ºC for 8). The presence of two 8-
amino-A and six 5-methyl-C produce a stabilization of the parallel duplex of 33 
ºC. The highest stabilization of the parallel duplex was obtained in the presence of 
two 8-amino-A and when the backbone of the Hoogsteen strand is replaced by 2’-
O-methyl-RNA (ΔTM 40 ºC for 13).  
A similar but less pronounced trend is observed in the melting temperatures of the 
triplexes. Melting temperatures of triplexes formed by 7, 9, 11 and 12 with their 
natural DNA target (S11WC) are between 40-47 ºC. The presence of two 8-
amino-A increase the TM values to 51-56 ºC (8 and 10 + S11WC), and  the 
presence of two 8-amino-A together with the replacement of the backbone of the 
Hoogsteen strand by 2’-O-methyl-RNA increases the TM values to 66 ºC (13 + 
S11WC). The presence of two 8-amino-A and six 5-methyl-C gave a TM value of 
only 51 ºC, the same TM as that of the hairpin alone. A similar result was observed 
at pH 7.0.  
When the target sequence has the 2’-O-methyl-RNA backbone (S11RNA), 
melting temperatures of  triplexes are slightly lower than triplexes formed with the 
DNA target (TM values of triplexes formed by 7, 9, 11 and 12  35-42 ºC;  TM 
values of triplexes formed by 8 and 10  52-55 ºC ) except the melting temperature 
of triplex formed by the hairpin 13, which is 71 ºC (the highest). This result is 
especially important because indicates that hairpins with mixed backbones bind 
more strongly to RNA targets.  
When the target sequence has 5-methyl-C instead of C (S11MeC), melting 
temperatures of triplexes are between 10-12 ºC higher than triplexes formed with 
the natural target sequence. This is 1.7-2 ºC per substitution, consistent with the 
stability afforded by the presence of the methyl group at position 5 of the C in the 
Watson-Crick position [40].  
Finally, the melting behavior of the triplex formed by the three-branch 
oligonucleotide (15) was compared with the melting behavior of the same triplex 
in which the strands are connected in different ways (Table 3). The triplex formed 
by three independent oligonucleotides (PurWC, S11WC, and S11) had two 
transitions at pH 6.0. The lower melting transition (20 ºC) corresponds to the 
dissociation of the Hoogsteen strand (S11) and the higher melting transition (50 
ºC) is due to the transition from a Watson-Crick duplex to a random coil. At 
higher pH only the duplex-to-random-coil transition is observed. At pH 5.5 the 
triplex-to-duplex transition is stabilized by protonation of C residues and the 
transition occurs at the same time as the duplex-to-random-coil transition.  
The connection of the Watson-Crick strands produces a stabilization of the 
Watson-Crick duplex structure without changing the stability of the triplex-to-
duplex transition. The melting temperature of the duplex-to-random-coil transition 
of the triplex formed by H26 and S11 is 82 ºC instead of 50 ºC, and the melting 
temperatures of the triplex-to-duplex transitions are 40 ºC and 20 ºC at pH 5.5 and 
pH 6.0.  
The connection of the Hoogsteen strand with the Watson-Crick purine strand 
produces the disappearance of the duplex-to-random-coil transition. Only one pH-
dependent transition is observed at pH between 4.5-7.0 and it is assigned to the 
triplex-to-random-coil transition. This was expected at pH 5.5-6.0 because of the 
high stabilization of the Hoogsteen pairing by linking the  Hoogsteen strand with 
the Watson-Crick purine. Two transitions were expected at pH 7.0, one being the 
duplex-to-random-coil at around 50 ºC. But instead, a single transition at 20 ºC (9 
+ S11WC) and 32 ºC (7 + S11WC) was observed. We believe this melting 
temperature is due to triplex-to-random-coil transition.  
The connection of the three strands repeats the same situation found with the three 
independent strands, but now with strong stabilization of both transitions. 
Oligonucleotide 15 has two transitions. The higher melting temperature (duplex-
to-random-coil transition) has the same value as the TM observed in the triplex 
H26 + S11 and it is pH-independent. The lower melting temperature (triplex-to-
duplex transition) shows a similar trend to the transitions observed in the triplexes 
9 + S11WC and 7 + S11WC and it is pH-dependent. This behavior indicates that 
oligonucleotide 15 has the expected triplex structure.   
 
Discussion.  The triplex-stabilizing properties of 8-aminopurines have triggered 
interest in the preparation of parallel hairpins for triplex formation [8]. In this 
paper we described the use of Fmoc-, trityl-protected asymmetric branching 
molecules for the preparation of parallel hairpins and three-armed 
oligonucleotides. This synthetic approach allows the preparation of parallel 
hairpins without the need of the reversed phosphoramidites, thus facilitating the 
preparation of parallel hairpins carrying modified bases and backbones. Most of 
the previous work in this area used nucleosides as branching units [13, 15, 17, 23, 
24] as the conformational rigidity imparted by the sugar could be exploited to 
preorganize and induce triplex formation. We preferred the use of the non-
nucleoside branching unit 1 because it is easy to prepare and it is free of possible 
side reactions described during the synthesis of branched RNA such as 
phosphoryl migration and/ or chain cleavage [10-12, 24]. 
All asymmetric branching molecules prepared carry two hydroxyl groups 
protected by orthogonal groups: one acid labile and one base labile. The acid 
labile group is always a trityl (MeOTr or (MeO)2Tr) derivative while the base 
labile group is frequently levulinyl group [10-21] and in some cases the tert-
butyldimethylsilyl group [24]. We believe that the extensive use of the levulinyl 
group is due to the optimal use in the synthesis of branched RNA to avoid 
phosphoryl migration. In our case this side reaction could not happen and  we 
selected the Fmoc group as base labile group. Although the conditions for the 
removal of the Fmoc group are very mild, this approach implies the removal of 
the Fmoc group in the middle of the synthesis to allow the second strand to grow. 
In this step, in addition to the Fmoc group, the CNE group of the phosphates of 
the assembled DNA half is also removed.  Little data was available on the 
possible consequences of the premature removal of the CNE groups of phosphates 
although the general feeling was positive due to the fact that during the synthesis 
of branched RNA the branching nucleoside should have unprotected 
phosphodiester function to prevent phosphoryl migration [24]. We found that 
coupling reactions are slower after branching. These difficulties in coupling last a 
few bases after branching, but after three or four bases, coupling becomes easier 
(as observed by the lack of the corresponding truncated sequences). This is 
consistent with results found during the synthesis of branched RNA [10-24] and it 
indicates that steric hindrance and electronwithdrawing effects of the groups at the 
branching site slow the coupling reactions more than the presence of unprotected 
phosphate groups. For these reasons difficulties in coupling at the branching point 
are easily overcome by increasing the coupling time, or by increasing the 
phosphoramidite concentration. On the other hand, changing the CNE group to a 
methyl group, changing oxidation conditions and addition of an extra washing 
step with DMAP-TET does not significantly improve coupling at the branching 
point. 
We have also measured the relative stability of purine-pyrimidine-pyrimidine 
triplexes formed by the parallel hairpins prepared in this work. RNA/DNA hybrid 
hairpins carrying 8-aminopurines and 2’-O-methyl-RNA at the Hoogsteen strand 
were found to have the best affinity for both DNA and 2’-O-methyl-RNA 
polypyrimidine targets. On the other hand, substitution of C by 5-methyl-C at the 
Hoogsteen position induced a high stabilization of the parallel structure but not of 
the triplex. During the preparation of this manuscript, the synthesis of 3’-3’-linked 
oligonucleotides branched by a pentaerythritol linker was described [21]. These 
authors also showed a high stabilization of triplexes formed by single-stranded 
DNA or RNA sequences with branched oligonucleotides composed of 2’-
deoxyribonucleotides and 2’-O-methylribonucleotides. Thus, our results are in 
agreement with these authors and indicate that parallel hairpins carrying 2’-O-
methyl-RNA and 8-aminoadenine have enhanced binding properties towards 
single-stranded polypyrimidine sequences by triplex formation.  
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Experimental Part 
 
General. Phosphoramidites and ancillary reagents used during oligonucleotide 
synthesis were from Applied Biosystems (PE Biosystems Hispania S.A., Spain), 
Cruachem (Cruachem Ltd., Scotland) and Glen Research (Glen Research Inc., 
USA). The rest of the chemicals were purchased from Aldrich, Sigma or Fluka 
(Sigma-Aldrich Química S.A., Spain). Long chain amino controlled pore glass 
(LCAA-CPG) was purchased from CPG (CPG, Inc., New Jersey, USA). Solvents 
were from S.D.S. (S.D.S., France). N,N’-Bis(4-hydroxybutyryl)-1,3-diamido-2-
propanol (1) was prepared as described elsewhere [19]. Instrumentation. 
Oligonucleotide sequences were synthesized on a Applied Biosystems DNA 
synthesizer model 392 (Applied Biosystems, USA). Mass spectra (matrix-assisted 
laser desorption ionization time-of-flight, MALDI-TOF) were provided by the 
Mass spectrometry service at the University of Barcelona. UV spectra and melting 
experiments were recorded on a Shimadzu UV-2101PC spectrophotometer 
equipped with temperature controller SPR-8. 1H-, and 13C-NMR spectra were 
recorded on a Varian Gemini 200MHz.  
 
N-[4-(4-methoxytrityloxy)butyryl]-N’-(4-hydroxybutyryl)-1,3-diamido-2-propanol 
(2). N,N’-Bis(4-hydroxybutyryl)-1,3-diamido-2-propanol (1, 5 g, 19 mmol) was 
dried after repeated evaporation of a solution in anhydrous pyridine and dissolved 
in 20 ml of pyridine. The solution was cooled over an ice-bath and treated 
dropwise with a solution of 2.89 g (9.3 mmol) of 4-methoxytrityl chloride in 20 
ml of dichloromethane (DCM) (over 30 min). After the addition the reaction 
mixture was gradually warmed to room temperature and stirred for 90 min. The 
reaction was stopped with the addition of 0.5 ml of metanol (MeOH) and the 
solution was concentrated to dryness. The residue was dissolved in 200 ml of 
DCM, and the organic solution was washed in 100 ml of 5% Na2CO3 aqueous 
solution, and 100 ml of saturated NaCl, dried (anhydrous Na2SO4) and 
concentrated to dryness. The residue was purified by column chromatography on 
silica gel. The column was packed with a 0.5% pyridine solution in DCM and 
eluted with a 0 to 5% gradient of MeOH in DCM to give 2.51 g (50%) of the 
desired compound. TLC (5% MeOH in DCM) Rf = 0.37. Anal. Calcd. For 
C31H38N2O6.2 H2O: C, 65.25; H, 7.42; N, 4.91. Found C, 65.84; H, 7.84; N, 4.92. 
Mass spectra (FAB+): 557.2 (M+Na), 273.1 (MeOTr+) expected for C31H38N2O6 
534.6. 1H-NMR (DMSO-d6) δ (ppm): 7.4-6.4 (m, 16 H, MeOTr, 2 NH), 4.6 (wide 
s, 1H, CHOH), 3.71 (s, 3H, OCH3), 3.6, 3.4, 3.2 (m, 8H, OH, CHOH, CH2OH, 
CH2NH), 3.0 (t, 2H, CH2O MeOTr), 2.3 (m, 4H, CH2CO), 1.8 (m, 4H, 
CH2CH2CH2). 13C-NMR (Cl3CD) δ (ppm): 174.1, 173.7 (2 CONH), 157.4 
(MeOTr), 143.6 (MeOTr), 134.8 (MeOTr), 129.2 (MeOTr), 127.3 (MeOTr), 
126.8 (MeOTr), 125.8 (MeOTr), 112.0 (MeOTr), 85.2 (Cq, MeOTr), 68.6 
(CHOH), 60.8, 61.4 (CH2OH and CH2O MeOTr), 54.2 (OCH3 MeOTr), 42.0 
(CH2NH), 32.4 (CH2CONH), 27.2 and 25.0 (CH2CH2CH2). 
 
N-[4-(9-fluorenylmethoxycarbonyloxy)butyryl]-N’-[4-(4-methoxytrityloxy) 
butyryl]-1,3-diamido-2-propanol (3). Compound 2 (0.63 g, 1.18 mmol) was 
dissolved in 10 ml of pyridine and reacted with 9-fluorenylmethoxycarbonyl 
chloroformate (0.31 g, 1.18 mmol). After 3.5 h stirring at room temperature, the 
reaction was stopped by addition of 0.5 ml of MeOH and the solution was 
concentrated to dryness. The residue was dissolved in 100 ml of DCM, and the 
organic solution was washed in 100 ml of saturated NaCl, dried (anhydrous 
Na2SO4) and concentrated to dryness. The residue was purified by column 
chromatography on silica gel. The column was packed with a 0.5% pyridine 
solution in DCM and eluted with a 0 to 5% gradient of MeOH in DCM to give 0.2 
g (23%) of the desired compound. TLC (5% MeOH in DCM) Rf = 0.78. Anal. 
Calcd. For C46H49N2O8: C, 72.90; H, 6.52; N, 3.70. Found C, 72.32; H, 6.46; N, 
3.37. Mass spectra (FAB+): 779.5 (M+Na), 273.2 (MeOTr+) expected for 
C46H49N2O8 757.9.  1H-NMR (DMSO-d6) δ (ppm): 7.9-6.8 (m, 24 H, MeOTr, 
Fmoc, 2 NH), 4.9 (d, 1H, CHOH), 4.4 (m, 2H, CH2 Fmoc), 4.18 (m, 1H, CH 
Fmoc), 3.75 (s, 3H, OCH3), 3.5 (m, 1H, CHOH), 3.4-2.9 (m, 8H, CH2O-MeOTr, 
CH2O-Fmoc, CH2NH), 2.4-2.2 (m, 4H, CH2CO), 2.1-1.8 (m, 4H, CH2CH2CH2). 
13C-NMR (DMSO-d6) δ (ppm): 173.4, 172.5 (CONH), 157.4 (MeOTr), 143.4 
(MeOTr), 142.6, 141.4, 140.2 (Fmoc), 129.5 (MeOTr), 127.0 (MeOTr, Fmoc), 
126.6 (MeOTr), 126.2, 125.9 (MeOTr, Fmoc), 124.2 (Fmoc), 118.9 (Fmoc), 85.2 
(Cq MeOTr), 69.7, 68.9, 66.4, 61.5 (CHOH, CH2O MeOTr, CH2OFmoc, CH2 
Fmoc), 54.5 (OCH3, MeOTr), 45.9 (CH Fmoc), 41.8 (CH2NH ), 32.8, 31.1 
(CH2CO), 25.4, 23.8 (CH2CH2CH2). 
 
Preparation of the solid support carrying the asymmetric doubler (5).  
Synthesis of the hemisuccinate 4. Compound 3 (0.2 g, 0.26 mmol) was reacted 
with 31 mg (0.31 mmol) of succinic anhydride in the presence of 38 mg (0.31 
mmol) of DMAP in 25 ml of DCM. The mixture was stirred for 20 h at room 
temperature and the resulting solution was diluted with 75 ml of DCM. The 
organic solution was washed in 75 ml of a 0.1 M NaH2PO4 (pH 5) followed by a 
saturated NaCl solution, dried (anhydrous Na2SO4) and concentrated to dryness. 
The residue was dissolved with the minimum amount of DCM and precipitated 
with hexane. Yield 0.2 g (0.23 mmol, 87%). The resulting white solid was 
partially contaminated with DMAP but it was used in the following step without 
further purification. 1H-NMR (DMSO-d6) δ (ppm): similar spectra to compound 3 
with the exception of a signal at 2.8 (m, 2H, HOOC-CH2). 
Coupling of the hemisuccinate to the solid support. The support carrying the 
asymmetric doubler was prepared by the coupling of the hemisuccinate 4  to 
sarcosyl-LCAA-CPG [41] using Ph3P, 2,2’-dithiobis(5-nitropyridine) and DMAP 
as condensing agents [42]. Coupling time was increased from 5 min to 45 min, 
which gave a functionalization of 34 μmol per g.   
 
Synthesis of branched oligonucleotides. Phosphoramidites of the natural bases 
(dAbenzoyl, dCbenzoyl, dGisobutyryl, and T) were from commercial sources. The 
phosphoramidite of 8-aminoadenine protected with the dimethylformamidine 
group was prepared as described elsewhere [3, 4]. 5-Methyl-dCbenzoyl, 2’-O-
methyl-U and 2’-O-methyl-Cbenzoyl, (MeO)2Tr -hexaethyleneglycol, and 
asymmetric doubler phosphoramidites were from commercial sources. 3’-O-
(MeO)2Tr -1,3-propanediol-succinyl-CPG support was prepared as described 
elsewhere [31]. Oligonucleotides were synthesized on a 1 and 0.2 μmol scale 
using a DNA synthesizer. The supports carrying the first half of the parallel 
hairpin were synthesized at 1 μmol scale. After the assembly of the first half of 
hairpins the (MeO)2Tr group at the 5’-end was removed and the resulting supports 
were treated as follows: A) Acetylation of the 5’-end: treatment of the trityl-off 
supports with 2 ml of a 1:1 mixture of the capping solutions from the DNA 
synthesizer ( A: acetic anhydride / lutidine / tetrahydrofuran (THF) 1:1:8) and B: 
10% N-methylimidazole in THF) for 10 min. B) Removal of the Fmoc group: 
treatment of the supports with 2 ml of 0.5 M DBU solution in ACN for 10 min. 
and washes in 1% triethylamine in ACN and ACN to eliminate excess of DBU. 
These supports were divided in several aliquots to test the assembly of the second 
half of the hairpins using several cycles of synthesis. The trials were performed at 
a 0.2 μmol scale. The following synthesis cycles were tried: I) Standard cycle 
(coupling time 30 s, capping time 15 s, oxidation time 30 s). II) Increased 
coupling time cycle: coupling time 5 min, capping time 75 s, oxidation time 75 s. 
III) Double coupling cycle: Two coupling reactions per base of 5 min, capping 
time 75 s, oxidation time 75 s. IV) Neutralization cycle: the standard cycle in 
which an additional step of neutralization with a solution of DMAP-TET was 
included between detritylation and coupling steps. V) Neutralization and 
increased coupling time cycle: The increased coupling time cycle in which an 
additional step of neutralization with a solution of DMAP-TET was included 
between detritylation and coupling steps.  VI) Neutralization and double coupling 
cycle: the double coupling cycle in which an additional step of neutralization with 
a solution of DMAP-TET was included between detritylation and coupling steps. 
VII) Anhydrous oxidation cycle. The standard cycle in which iodine solution was 
substituted by a t-butylhydroperoxide solution (20 ml of the commercially 
available solution in decane (5-6 M) was mixed with 40 ml of dichloromethane), 
oxidation time was increased to 1 min. Finally the phosphoramidite concentration 
was 0.1 M but in some cases a 0.2 M solution was also used. 
The three-branched oligonucleotide (15) was prepared on 0.2 μmol using 
polystyrene supports (LV200 columns). The first two branches were assembled 
using the standard cycle recommended for these columns. After capping and 
removal of the Fmoc group as described above, the third branch was assembled 
using the same cycle but with increased coupling time (8 min). 
After the assembly of the sequences, oligonucleotide-supports were treated with 
32% aqueous ammonia at 55 ºC. When O-methyl phosphoramidites were used, 
supports were first treated with 1 ml of thiophenol / triethylamine /dioxane (1:1:2) 
for 2 h at room temperature, washed in ACN and dried. The resulting supports 
were then treated with concentrated ammonia. Ammonia solutions were 
concentrated to dryness and the products were purified by reversed-phase HPLC. 
Oligonucleotides were synthesized with the last (MeO)2Tr group at the 5' end 
(trityl-on protocol) to facilitate reverse-phase purification. HPLC conditions: 
Solvent A: 5% ACN in 100 mM triethylammonium acetate (TEAA) pH 6.5 and 
solvent B: 70% ACN in 100 mM TEAA pH 6.5. Columns: PRP-1 (Hamilton), 250 
x 10 mm. Flow rate: 3 ml/min. A 30 min linear gradient from 10-80% B (trityl on) 
or a 30 min linear gradient from 0-50% B (trityl off). MS (MALDI-TOF) of 
sequence 11: 8358.9 (M+4Na+) expected for C265H323N93O165P26 8275.4). 
Oligonucleotides were also checked by denaturing gel electrophoresis. In this 
case, a small aliquot of the (MeO)2Tr-oligonucleotide was detritylated with 80% 
acetic acid and dried. The resulting product was loaded in the gel using glycerol 
loading buffer for the analysis of the purity.  
Yields after purification. 11 (200 nmols), 8 OD units (cycle II). 12 (200 nmols), 7 
OD units (cycle III). 13 (200 nmols), 3 OD units. 14 (200 nmols), 2 OD units, 15 
(200 nmols), 4 OD units. Sequences 7-10 were prepared in polystyrene supports 
(200 nmols) and the amount obtained after the same HPLC purification were 
between 5-10 OD units [8]. 
 
Melting experiments. Melting experiments with triple helices were performed as 
follows. Solutions of equimolar amounts of hairpins and the target Watson-Crick 
pyrimidine strand (11-mer) were mixed in 0.1 M sodium phosphate / citric acid 
buffer of pH ranging from 4.5 to 7.0 and 1M NaCl. The DNA concentration was 
determined by UV absorbance measurements (260 nm) at 90 ºC, using for the 
DNA coil state the following extinction coefficients: 7500, 8500, 12500, 15000 
and, 15000 M-1 cm-1 for C, T, G, A and, 8-amino-A, respectively. The solutions 
were heated to 90 ºC, allowed to cool slowly to room temperature, and stored at 
4ºC until UV was measured. UV absorption spectra and melting experiments 
(absorbance vs temperature) were recorded in 1 cm path-length cells using a 
spectrophotometer, with a temperature controller and a programmed temperature 
increase rate of 0.5 ºC/min. Melts were run on duplex concentration of 3-4 μM at 
260 nm. 
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 Table 1: Sequences of parallel hairpins and a three-branched oligonucleotide 
prepared. 
 
Number Sequencea) 
7 5’-GAAGGAGGAGA-heg-TCTCCTCCTTC-5’ 
8 5’-GAAGGNGGNGA-heg-TCTCCTCCTTC -3’ 
9 3’-AGAGGAGGAAG-heg-CTTCCTCCTCT-3’ 
10 3’-AGNGGNGGAAG-heg-CTTCCTCCTCT-3’ 
11 5’-GAAGGAGGAGA-TT-bpa-TT-TCTCCTCCTTC-5’ 
12 5’-GAAGGAGGAGA-TT-bppd-TT-TCTCCTCCTTC-5’ 
13 5’- GAAGGNGGNGA -TT-bppd-UU-UCUCCUCCUUC-5’ 
14 5’- GAAGGNGGNGA -TT-bppd-TT-TMTMMTMMTTM-5’ 
15 5’-GAAGGAGGAGA-heg-bpp-(heg-CTTCCTCCTCT-5’)-heg-TCTCCTCCTTC-5’
a)heg: hexaethyleneglycol, bpa: [-PO3-O(CH2)3-CONH-CH2]2-CHOH, bppd: [-
PO3-O(CH2)4-CONH-CH2]2-CHOPO2OCH2CH2CH2OH,  bpp: [-PO3-O(CH2)4-
CONH-CH2]2-CHOPO3-, N: 8-aminoadenine, M: 5-methylcytosine, U,C: 2-O’-
methyl-RNA  
 
Table 2. Melting temperatures (ºC) of parallel hairpins and triplexes in 0.1 M 
sodium phosphate and citric acid pH 6.0 and pH 7.0 (last entry), 1 M NaCl. S11: 
5’-CTTCCTCCTCT-3’; S11RNA: 5’-CUUCCUCCUCU-3’; S11MeC: 5’-
MTTMMTMMTMT-3’. C,U: 2’-O-methyl-RNA and M: 5-methylcytidine; the 
rest of the sequences are described in Table 1. 
 
Hairpin No target 
Target 
S11WC 
Target 
S11RNA 
Target 
S11MeC 
9 25 45 38 55 
7 25 47 42 58 
12 18 40 35 52 
11 24 43 36 53 
8 43 56 55 -- 
10 38 51 52 62 
13 58 66 71 -- 
14, pH 6.0 51 51 -- 63 
14, pH 7.0 29 32 -- -- 
Table 3. Melting temperatures (ºC) of triplexes having different constrains in 0.1 
M sodium phosphate and citric acid, 1 M NaCl. H26: 5’-GAAGGAGGAGA-T4-
TCTCCTCCTTC-3’; S11: 5’-CTTCCTCCTCT-3’; S11WC: 5’-TCTCCTCCTTC-
3’; PurWC: 5’-GAAGGAGGAGA-3’; the rest of the sequences are described in 
Table 1. 
Triplex  pH 5.5 pH 6.0 pH 6.5 pH 7.0 
H26+S11 
 
40 / 82 20 / 82 -- / 82 -- / 82 
15 
 
54 / 80 38 / 80 27 / 82 15 / 80 
PurWC+ 
S11WC+S11 
 
44* 20 / 50 -- / 50 -- / 50 
9+S11WC 
 
54* 45* 33* 20* 
7+S11WC 3'-CTTCCTCCTCT-5'
5'-GAAGGAGGAGA
: : : : : : : : : : :
5'-CTTCCTCCTCT
(EG)6
 
56* 47* 36* 32* 
 *Triplex-to-random-coil transition 
 
 
3'-CTTCCTCCTCT-5'
5'-GAAGGAGGAGA-3'
: : : : : : : : : : :
5'-CTTCCTCCTCT-3'
3'-CTTCCTCCTCT
5'-CTTCCTCCTCT-3'
5'-GAAGGAGGAGA
T
T T
T
: : : : : : : : : : :
3'-CTTCCTCCTCT
5'-CTTCCTCCTCT
5'-GAAGGAGGAGA
: : : : : : : : : : :
3'-CTTCCTCCTCT-5'
GAAGGAGGAGA-3'
: : : : : : : : : : :
CTTCCTCCTCT-3'
(EG)6
 LEGENDS 
Scheme 1. Scheme of two possible ways to assemble 3’-3’ linked DNA hairpins 
with the two arms in parallel orientation. A) Standard method. The synthesis starts 
at one end of the hairpin. The first half is assembled using reversed 
phosphoramidites followed by the assembly of the second half using standard 
phosphoramidites. B) Method using branching molecules. The hairpin is 
assembled from the loop using a branching molecule which carries two hydroxyl 
groups protected by orthogonal groups: the acid labile dimethoxytrityl ((MeO)2Tr) 
and the base labile fluorenylmethoxycarbonyl (Fmoc). This last method does not 
require the use of reversed phosphoramidites.  
Scheme 2. Synthesis of the support carrying the asymmetric branching molecule. 
Scheme 3. Outline of the synthesis of parallel hairpin 11. 
Scheme 4. Outline of the synthesis of oligonucleotide 15. 
 
Figure 1. Analysis by gel electrophoresis (20% acrylamide, 8M urea) of the 
products obtained after the assembly of the parallel hairpin 11 obtained using: A) 
standard cycle; B) Increased coupling time; C) double coupling; D) same as A but 
adding a wash in DMAP-TET; E)  same as B but adding a wash in DMAP-TET; 
F) same as C but adding a wash in DMAP-TET. 
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CTTCCTCCTCT-(EG)6O-(MeO)2Tr
AGAGGAGGAAG-O-(MeO)2Tr
3' 5'
3' 5'
3' 5'
O-Fmoc3' 5'
CTTCCTCCTCT-(EG)6O
AGAGGAGGAAG-O-Acetyl
3' 5'
OH3' 5'
CTTCCTCCTCT-(EG)6O
AGAGGAGGAAG-O-Acetyl
3' 5'
TCTCCTCCTTC-O-(MeO)2Tr3' 5'
CTTCCTCCTCT-(EG)6O
15
Figure 1 
 
 
 
26 mer + XC 
A    B    C    D    E     F     
13 mer 
BPB 
